In an observational study of 205 patients with bloodstream infections caused by strains of carbapenemase-producing Klebsiella pneumoniae, mortality was higher in patients who received monotherapy vs. those treated with combination therapy (44.4% vs 27.2%, P = 0.018).
In an observational study of 205 patients with bloodstream infections caused by strains of carbapenemase-producing Klebsiella pneumoniae, mortality was higher in patients who received monotherapy vs. those treated with combination therapy (44.4% vs 27.2%, P = 0.018).
Combination Therapy for Carbapenemase-Producing Klebsiella pneumoniae Bacteremia Reduces Mortality
May 1, 2014